A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of ...

New York is opening the floodgates for more medical providers to administer fluoride to kids as President-elect Donald ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

Left atrial appendage closure is an alternative strategy for stroke prophylaxis, Wazni and colleagues noted. "The safety and ...

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.

Until my mid-40s, my approach to gum health was, at best, sporadic. I had always suspected that flossing was one of those ...

WASHINGTON -- Giant cell arteritis (GCA) can be successfully treated with the oral Janus kinase (JAK) inhibitor upadacitinib ...

After Alaska became the first state to start a dental therapy program in 2006, with a rocus on rural servie, other states ...

An international team of researchers has uncovered evidence of partial resistance to artemisinin derivatives -- the primary treatment for malaria -- in young children with severe malaria.

Treatments for hair regrowth include medicated formulas, supplements, lasers, and complementary remedies, such as massage and ...

MNKD-201, an inhaled formulation of nintedanib for IPF, was shown to be safe and well tolerated in a clinical trial with ...